The PharmaThene agreement may be a bigger deal than it appears on the surface.
PharmaThene is in the process of going public through an acquisition by Healthcare Acquisition Corporation (Amex: HAQ) ... scheduled to close this summer. The following is a power point presentation by HAQ for prospective investors, but it makes interesting reading as to what is forecast in revenues for Protexia.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.